Literature DB >> 17502463

Genetic models of migraine.

Rob C G van de Ven1, Simon Kaja, Jaap J Plomp, Rune R Frants, Arn M J M van den Maagdenberg, Michel D Ferrari.   

Abstract

Migraine is a common, disabling, complex brain disorder, presenting in attacks that may have up to 3 phases: a prodromal phase, the aura phase, and the headache phase. The pathogenesis of the aura and headache phases is reasonably well understood, but the mechanism by which migraine attacks are triggered is unknown. Most likely, migraineurs have a genetically determined reduced threshold for migraine triggers. Identifying "threshold genes" and deciphering their function will help to unravel the triggering mechanisms for migraine attacks. Familial hemiplegic migraine is a rare monogenic subtype of migraine with aura. Three genes have been identified for familial hemiplegic migraine. Recently, knock-in mice carrying human pathogenic FHM1 mutations were generated, which show behavioral, electrophysiological, and neurobiological characteristics in line with prevailing views of migraine physiological processes. Genetic migraine models will be useful in unraveling the triggering mechanisms for migraine attacks and in identifying novel migraine prophylactic targets and therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502463     DOI: 10.1001/archneur.64.5.643

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  A genome-wide association study of bipolar disorder and comorbid migraine.

Authors:  K J Oedegaard; T A Greenwood; S Johansson; K K Jacobsen; A Halmoy; O B Fasmer; H S Akiskal; J Haavik; J R Kelsoe
Journal:  Genes Brain Behav       Date:  2010-06-29       Impact factor: 3.449

Review 2.  CGRP receptor antagonism and migraine.

Authors:  Lars Edvinsson; Tony W Ho
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 3.  Cerebral angiopathies as a cause of ischemic stroke in children: differential diagnosis and treatment options.

Authors:  Hans-Jakob Steiger; Daniel Hänggi; Birgit Assmann; Bernd Turowski
Journal:  Dtsch Arztebl Int       Date:  2010-12-03       Impact factor: 5.594

4.  A homolog of FHM2 is involved in modulation of excitatory neurotransmission by serotonin in C. elegans.

Authors:  Elena G Govorunova; Mustapha Moussaif; Andrey Kullyev; Ken C Q Nguyen; Thomas V McDonald; David H Hall; Ji Y Sze
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

5.  The S218L familial hemiplegic migraine mutation promotes deinhibition of Ca(v)2.1 calcium channels during direct G-protein regulation.

Authors:  Norbert Weiss; Alejandro Sandoval; Ricardo Felix; Arn Van den Maagdenberg; Michel De Waard
Journal:  Pflugers Arch       Date:  2008-06-26       Impact factor: 3.657

6.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

7.  A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11.

Authors:  K J Oedegaard; T A Greenwood; A Lunde; O B Fasmer; H S Akiskal; J R Kelsoe
Journal:  J Affect Disord       Date:  2009-10-12       Impact factor: 4.839

Review 8.  [Pathophysiology of migraine and clinical implications].

Authors:  M Schürks; H-C Diener
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

Review 9.  Migraine and psychiatric comorbidity: a review of clinical findings.

Authors:  Fabio Antonaci; Giuseppe Nappi; Federica Galli; Gian Camillo Manzoni; Paolo Calabresi; Alfredo Costa
Journal:  J Headache Pain       Date:  2011-01-06       Impact factor: 7.277

Review 10.  New directions in migraine.

Authors:  Greg A Weir; M Zameel Cader
Journal:  BMC Med       Date:  2011-10-25       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.